東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Biomarkers for endometriosis = state...

SpringerLink (Online service)

FindBook

Google Book

Amazon

博客來

Biomarkers for endometriosis = state of the art /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Biomarkers for endometriosis/ edited by Thomas D'Hooghe.
其他題名:	state of the art /
其他作者:	D'Hooghe, Thomas.
出版者:	Cham :Springer International Publishing : : 2017.,
面頁冊數:	xii, 267 p. :ill., digital ;24 cm.
內容註:	Biomarker development: general concepts and state of the art in medicine -- Biomarker development in chronic inflammatory diseases -- Biomarker development in cancer -- Biomarker development in ovarian cancer -- Biomarker development in endometrial cancer -- Biomarker development in breast cancer -- Biomarker development in reproductive medicine -- Industry perspective on biomarker development in medicine -- Biomarker development in endometriosis -- Health economic impact of endometriosis -- Patient perspective on biomarker development for endometriosis -- Genetic biomarkers for endometriosis -- Epidemiological and clinical risk factors for endometriosis -- Peripheral blood biomarkers for endometriosis -- Endometrial biomarkers for endometriosis -- Biomarkers for endometriosis in saliva, urine and peritoneal fluid -- mRNA and miRNA biomarkers for endometriosis -- Proteomic biomarkers for endometriosis -- Multiprotein arrays and endometriosis -- Metabolomics and endometriosis -- Harmonization of clinical and laboratory data to improve biomarker discovery in endometriosis -- Endometriomics and biomarker development in endometriosis.
Contained By:	Springer eBooks
標題:	Endometriosis - Diagnosis. -
電子資源:	http://dx.doi.org/10.1007/978-3-319-59856-7
ISBN:	9783319598567

Biomarkers for endometriosis = state of the art /
Biomarkers for endometriosisstate of the art /[electronic resource] :edited by Thomas D'Hooghe. - Cham :Springer International Publishing :2017. - xii, 267 p. :ill., digital ;24 cm.

Biomarker development: general concepts and state of the art in medicine -- Biomarker development in chronic inflammatory diseases -- Biomarker development in cancer -- Biomarker development in ovarian cancer -- Biomarker development in endometrial cancer -- Biomarker development in breast cancer -- Biomarker development in reproductive medicine -- Industry perspective on biomarker development in medicine -- Biomarker development in endometriosis -- Health economic impact of endometriosis -- Patient perspective on biomarker development for endometriosis -- Genetic biomarkers for endometriosis -- Epidemiological and clinical risk factors for endometriosis -- Peripheral blood biomarkers for endometriosis -- Endometrial biomarkers for endometriosis -- Biomarkers for endometriosis in saliva, urine and peritoneal fluid -- mRNA and miRNA biomarkers for endometriosis -- Proteomic biomarkers for endometriosis -- Multiprotein arrays and endometriosis -- Metabolomics and endometriosis -- Harmonization of clinical and laboratory data to improve biomarker discovery in endometriosis -- Endometriomics and biomarker development in endometriosis.

This book presents an overview of the diagnostic performance of non- or semi-invasive tests for endometriosis in peripheral blood, endometrium, saliva, peritoneal fluid and urine. The value of existing and emerging systems biology technologies for biomarker development is addressed in several chapters on genetics, microarrays, proteomics and metabolomics. Although tests with high sensitivity and acceptable specificity have been developed, sometimes validated in independent populations and seem promising, more research is needed to translate these data into clinical benefit for patients and coordinate efforts internationally to standarize analysis, reports and operating procedures. The gold standard to diagnose endometriosis is currently through laparoscopic inspection with histological confirmation, a surgical procedure with rare but significant potential risks for the patients. A non-invasive test for endometriosis would be critical for the early detection of endometriosis of symptomatic women with pelvic pain and/or subfertility with normal ultrasound. This would include nearly all cases of minimal-mild endometriosis, some cases of moderate-severe endometriosis without a clearly visible ovarian endometrioma and cases with pelvic adhesions and/or other pelvic pathology, who might benefit from surgery to improve pelvic pain and/or subfertility. Such a test would also be useful in symptomatic women with ultrasound imaging suspicious for endometriosis, since it may be difficult to differentiate an ovarian endometrioma from other ovarian cysts and since the quality of ultrasound imaging is highly variable worldwide.

ISBN: 9783319598567

Standard No.: 10.1007/978-3-319-59856-7doiSubjects--Topical Terms:

3259236
Endometriosis
--Diagnosis.

LC Class. No.: RG483.E53

Dewey Class. No.: 618.1075

Biomarkers for endometriosis = state of the art /
LDR:03715nmm a2200313 a 4500 001 2109164
003 DE-He213
005 20180208133632.0
006 m d
007 cr nn 008maaau
008 180519s2017 gw s 0 eng d
020 $a 9783319598567 $q (electronic bk.)
020 $a 9783319598543 $q (paper)
024 7 $a 10.1007/978-3-319-59856-7 $2 doi
035 $a 978-3-319-59856-7
040 $a GP $c GP
041 0 $a eng
050 4 $a RG483.E53
072 7 $a MFKC $2 bicssc
072 7 $a HEA039060 $2 bisacsh
082 0 4 $a 618.1075 $2 23
090 $a RG483.E53 $b B615 2017
245 0 0 $a Biomarkers for endometriosis $h [electronic resource] : $b state of the art / $c edited by Thomas D'Hooghe.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2017.
300 $a xii, 267 p. : $b ill., digital ; $c 24 cm.
505 0 $a Biomarker development: general concepts and state of the art in medicine -- Biomarker development in chronic inflammatory diseases -- Biomarker development in cancer -- Biomarker development in ovarian cancer -- Biomarker development in endometrial cancer -- Biomarker development in breast cancer -- Biomarker development in reproductive medicine -- Industry perspective on biomarker development in medicine -- Biomarker development in endometriosis -- Health economic impact of endometriosis -- Patient perspective on biomarker development for endometriosis -- Genetic biomarkers for endometriosis -- Epidemiological and clinical risk factors for endometriosis -- Peripheral blood biomarkers for endometriosis -- Endometrial biomarkers for endometriosis -- Biomarkers for endometriosis in saliva, urine and peritoneal fluid -- mRNA and miRNA biomarkers for endometriosis -- Proteomic biomarkers for endometriosis -- Multiprotein arrays and endometriosis -- Metabolomics and endometriosis -- Harmonization of clinical and laboratory data to improve biomarker discovery in endometriosis -- Endometriomics and biomarker development in endometriosis.
520 $a This book presents an overview of the diagnostic performance of non- or semi-invasive tests for endometriosis in peripheral blood, endometrium, saliva, peritoneal fluid and urine. The value of existing and emerging systems biology technologies for biomarker development is addressed in several chapters on genetics, microarrays, proteomics and metabolomics. Although tests with high sensitivity and acceptable specificity have been developed, sometimes validated in independent populations and seem promising, more research is needed to translate these data into clinical benefit for patients and coordinate efforts internationally to standarize analysis, reports and operating procedures. The gold standard to diagnose endometriosis is currently through laparoscopic inspection with histological confirmation, a surgical procedure with rare but significant potential risks for the patients. A non-invasive test for endometriosis would be critical for the early detection of endometriosis of symptomatic women with pelvic pain and/or subfertility with normal ultrasound. This would include nearly all cases of minimal-mild endometriosis, some cases of moderate-severe endometriosis without a clearly visible ovarian endometrioma and cases with pelvic adhesions and/or other pelvic pathology, who might benefit from surgery to improve pelvic pain and/or subfertility. Such a test would also be useful in symptomatic women with ultrasound imaging suspicious for endometriosis, since it may be difficult to differentiate an ovarian endometrioma from other ovarian cysts and since the quality of ultrasound imaging is highly variable worldwide.
650 0 $a Endometriosis $x Diagnosis. $3 3259236
650 0 $a Biochemical markers. $3 587592
650 1 4 $a Medicine & Public Health. $3 890906
650 2 4 $a Reproductive Medicine. $3 874352
650 2 4 $a Bioinformatics. $3 553671
650 2 4 $a Human Genetics. $3 891169
700 1 $a D'Hooghe, Thomas. $3 3259235
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-59856-7
950 $a Medicine (Springer-11650)